Losing a health plan is stressful at any age. Losing it in retirement, when a familiar doctor and a specific drug list are woven into daily life, is worse. Yet that is exactly what happened to a large group of older Americans, and the trend that caused it is not finished.

Roughly 2.6 million people enrolled in a Medicare Advantage prescription drug plan in 2025 had that coverage terminated at the end of the year, after insurers discontinued plans or pulled out of the areas where they were sold. With another open enrollment season approaching, anyone on a Medicare Advantage plan should understand why this is happening and how to keep a coverage gap from catching them by surprise.

Why Insurers Are Retreating

Medicare Advantage, the privately run alternative to Original Medicare, spent a decade growing on generous federal payments. That era cooled. By 2026, government reimbursement had fallen by roughly 20% from 2023 levels, while medical costs kept climbing, and insurers responded by cutting plans that no longer earned their keep.

The pullback among the biggest carriers is striking. UnitedHealth Group Inc. (NYSE:UNH) exited 225 counties for 2026 while entering only 14, and Humana Inc. (NYSE:HUM) left 198 counties, trimmed its service area to 85% of U.S. counties from 89%, and dropped out of three states entirely. On the drug-plan side, the Aetna unit of CVS Health Corp. (NYSE:CVS) offered standalone Part D plans in about 100 fewer counties than the year before.

The result is fewer choices. The average Medicare beneficiary had access to 32 Medicare Advantage prescription drug plans for 2026, down from 34 a year earlier, and in most states the count fell. The good news, according to the same research, is that most people hit by plan terminations still had other Medicare Advantage options available to them. A replacement usually exists. It just may not match the plan that vanished.

How To Tell If Your Plan Is On The Chopping Block

You do not have to guess. Every fall your insurer must mail an Annual Notice of Change, generally by the end of September, spelling out what is changing for the coming year. If a plan is being discontinued, you also receive a separate non-renewal notice. Reading that mail rather than tossing it is the single most important step, because a plan termination that goes unnoticed can leave you without drug coverage and exposed to a late-enrollment penalty.

Two enrollment windows give you room to act. The Medicare Annual Enrollment Period runs from October 15 to December 7 and lets you switch plans for the following year. If your specific plan is terminated, that qualifies you for a Special Enrollment Period, which extends your window to choose a replacement without a coverage gap.

What To Do If Yours Disappears

Start by comparing the replacement plans in your area on the drugs and doctors you actually use, not the headline premium. A cheaper plan that drops your medication from its formulary or your physician from its network can cost far more in practice than a slightly pricier plan that keeps both.

You also have the option to leave Medicare Advantage entirely and return to Original Medicare, usually paired with a standalone Part D drug plan. That path carries a trap worth knowing in advance. You cannot hold a Medigap supplement policy while enrolled in Medicare Advantage, so you would need to disenroll first. In most states, buying Medigap later can require medical underwriting, which lets insurers weigh your health history. A plan termination can open a limited guaranteed-issue window for Medigap in some cases, but the rules vary by state, so verifying your rights with Medicare or your State Health Insurance Assistance Program before you switch can prevent an expensive surprise.

What It Means For Investors

The same retreat that unsettles enrollees is a deliberate margin move for the companies behind these plans. UnitedHealth, Humana, and CVS are shedding unprofitable Medicare Advantage business to protect earnings, a strategy that can lift profitability even as membership falls. For investors, the metric to track is how well each insurer manages medical costs relative to government payments, rather than how many members it has.

The picture for 2027 may steady somewhat, since Medicare Advantage plans are set to receive an average federal payment increase of about 2.48%, worth roughly $13 billion, which could slow the pace of exits. Even so, the balance of power has shifted, and insurers have shown they will drop markets that do not pay. That makes plan stability, not just plan price, a factor worth weighing for both patients and shareholders.

Your Move Before Open Enrollment

The wave of terminations is a reminder that a Medicare Advantage plan is not a permanent fixture. The readers who avoid a scramble are the ones who open the fall mail, confirm whether their plan survives into the new year, and compare drug and doctor replacements before the December 7 deadline.

None of this is investment advice, and readers should confirm current plan details and enrollment rules with Medicare, their insurer, or their State Health Insurance Assistance Program before acting.

Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.